Dark

Check out our Dark Pool Levels

TTNP
TITAN PHARMACEUTICAL INC
stock NASDAQ

At Close

Jul 3, 2025

4.40USD+1.149%(+0.05)18,730

0.00Bid 0.00Ask 0.00Spread

Pre-market

Jun 30, 2025 9:00:30 AM EDT

4.25USD-2.299%(-0.10)829

After-hours

0.00USD0.000%(0.00)0

OverviewHistoricalExchangesShortsNews

Dec 21, 2021

08:03AM EST Titan Pharma To Explore Strategic Alternatives; Stock Up RTTNews

08:03AM EST Titan Pharma To Explore Strategic Alternatives Benzinga

08:02AM EST Titan Pharmaceuticals to Explore Strategic Alternatives PR Newswire

Nov 8, 2021

04:15PM EST Sustained Anti-Pruritic Effect Of Titan's TP-2021 Implant Reported Today At PR Newswire

Nov 5, 2021

04:31PM EDT Titan Announces Upcoming TP-2021 Implant Data Presentation at Neuroscience 2021 PR Newswire

Oct 25, 2021

07:19AM EDT Titan Pharma Gets Funding From Bill & Melinda Gates Foundation To Develop HIV Therapeutic And Contraceptive Implant RTTNews

07:18AM EDT Titan Pharmaceuticals Receives Funding to Develop Combination HIV Therapeutic and Contraceptive Implant for Women in Developing Countries Benzinga

07:15AM EDT Titan Pharmaceuticals Receives Funding to Develop Combination HIV Therapeutic PR Newswire

Oct 12, 2021

08:25AM EDT Titan Pharmaceuticals And MUSC FRD Enter Into Research And Option License Agreement; Financial Details Not Disclosed Benzinga

08:13AM EDT The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology Benzinga

08:11AM EDT Titan Pharma Enters Research And Option License Agreement With MUSC Foundation For Research Development RTTNews

08:02AM EDT Titan Pharmaceuticals and MUSC FRD Enter Into Research and Option License PR Newswire

Oct 7, 2021

08:24AM EDT The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results Benzinga

Oct 6, 2021

07:33AM EDT The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal Benzinga

Oct 5, 2021

08:01AM EDT The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout Benzinga

Oct 1, 2021

07:56AM EDT The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO Benzinga

Sep 30, 2021

07:43AM EDT The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug Benzinga

Sep 29, 2021

08:13AM EDT The Daily Biotech Pulse: AbbVie's Migraine Drug OK'd By FDA, Amicus Spins Off Gene Therapy Business, Geovax In-Licenses Cancer Drug Benzinga

Sep 23, 2021

07:57AM EDT The Daily Biotech Pulse: Restricted Authorization For Pfizer's COVID-19 Booster Dose, AbCellera Strikes Antibody Licensing Deal, Solid Biosciences Issues DMD Data Benzinga

Sep 22, 2021

07:45AM EDT The Daily Biotech Pulse: Pfizer-BioNTech US Vaccine Contract, Summit Slumps On Adverse Regulatory Feedback, Cerevel CFO Departs Benzinga

Sep 21, 2021

08:20AM EDT The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data Benzinga

Sep 17, 2021

07:36AM EDT The Daily Biotech Pulse: Adcom Tryst For Pfizer/BioNTech Booster Shot, AbCellera's COVID Antibody Treatment Gets Expanded Use, Protagonist Slapped With Clinical Hold Benzinga

Sep 16, 2021

07:48AM EDT The Daily Biotech Pulse: Leap, Phio, Silverback Among Early Movers On Oncology Conference Presentations, Aerie Slumps On Mixed Data, Axsome Commences Phase 3 Sleep Disorder Study Benzinga

Aug 31, 2021

09:53AM EDT Titan Medical Granted U.S. Patent Titled 'Alignment difference safety in a master-slave robotic system' Benzinga

Aug 20, 2021

07:45AM EDT The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data Benzinga

Aug 17, 2021

08:28AM EDT The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business Benzinga

Jun 23, 2021

08:08AM EDT Titan Pharma Announces Positive Results From TP-2021 Implant In Established Animal Model Of Chronic Pruritus RTTNews

08:08AM EDT Titan Announces Results From First Studies Of TP-2021 Implant In Established Animal Model Of Chronic Pruritus Benzinga

08:01AM EDT Titan Announces Positive Results from the First Studies of TP-2021 Implant in PR Newswire

Apr 16, 2021

08:01AM EDT The Daily Biotech Pulse: Precision Biosciences Regains Rights To CAR T Candidates, CFO Changes, 2 IPOs Benzinga

Apr 15, 2021

07:49AM EDT The Daily Biotech Pulse: Merck Shelves 2 COVID-19 Studies, Bristol-Myers Squibb Gets European Regulatory Nod, InspireMD's Reverse Split Benzinga

Apr 14, 2021

07:51AM EDT The Daily Biotech Pulse: Novavax CFO Departs, Zai Lab Inks Cancer Drug Collaboration, FDA Nod For Gilead Benzinga

Apr 13, 2021

08:16AM EDT The Daily Biotech Pulse: Leadership Transition At Amarin, Vaccine Setback For J&J, FDA Nod For Label Expansion of Roche's Asthma Drug Benzinga

Mar 31, 2021

04:32PM EDT Titan Pharma FY20 EPS $(1.96) vs $(9.78) In Same Qtr. Last Year Benzinga

04:31PM EDT Titan Pharmaceuticals Announces Filing Of 2020 Annual Report On Form 10-K PR Newswire

Feb 18, 2021

10:02AM EST Benzinga's Top Ratings Upgrades, Downgrades For February 18, 2021 Benzinga

07:32AM EST Maxim Group Upgrades Titan Pharmaceuticals to Buy, Announces $11 Price Target Benzinga

Feb 1, 2021

10:28AM EST Shares of Titan Pharmaceuticals, Inc. (TTNP) are currently gaining over 18% after the company announced positive early study results from its JT-09 ProNeura development program. RTTNews

07:35AM EST Titan Pharmaceuticals Says Studies Of Its Kappa Opioid Agonist Peptide, JT-09, 'demonstrated high potency and specificity for the human kappa-opioid receptor' Benzinga

07:31AM EST Positive Early Study Results Help Pave Wave for Titan Pharmaceuticals to Move PR Newswire

Jan 27, 2021

05:05PM EST Titan Pharmaceuticals Inc Files For Resale Of Up To 2.73M Shares Of Common Stock By The Selling Stockholders Benzinga

Jan 25, 2021

08:28AM EST Titan Pharma 13G Filing From L1 Capital Shows 6.9% Stake In Co. Benzinga

Jan 15, 2021

09:17AM EST Titan Pharma Announces Pricing Of $9.7 Mln Registered Direct Offering RTTNews

09:16AM EST Titan Pharmaceuticals Announces Pricing Of $9.7M Offering Benzinga

09:16AM EST Titan Pharmaceuticals Announces Pricing of $9.7 Million Registered Direct PR Newswire

Dec 16, 2020

08:04AM EST Titan Pharmaceuticals Regains Compliance With Nasdaq Listing Requirements Benzinga

Dec 1, 2020

10:21AM EST Mid-Morning Market Update: Markets Open Higher; Nio November Deliveries Surge 109% Benzinga

08:08AM EST The Daily Biotech Pulse: Pfizer, BioNTech File Marketing Application In Europe, NuCana Jumps On Data, Amarin Takes On Hikma In Patent Lawsuit Benzinga

Nov 30, 2020

01:36PM EST Titan Pharmaceuticals Announces 1-for-30 Reverse Stock Split RTTNews

12:57PM EST Titan Pharma Reports Board Approved 1-For-30 Reverse Stock Split, Effective Dec. 1, 2020 Benzinga

12:50PM EST Titan Pharmaceuticals Announces Reverse Stock Split PR Newswire

Nov 19, 2020

02:57PM EST Yahoo Finance Trending Stocks For Thursday, Nov. 19, 2020: SONO, ROKU, ZBRA, SBE, NVDA, YY, COTY, BILI, BLNK, XPEV, AMD, AYRO, SOLO, SQ, CIIC, BABA, TDOC, TLS, FENG, SHOP, WPX, TWLO, LPX, CSIQ, GEVO, TTNP, NNDM, SNAP, FMCKM, MDGS Benzinga

05:53AM EST What's moving these stocks in the pre-market hours today? RTTNews

Nov 16, 2020

08:46AM EST Titan Pharmaceuticals Q3 EPS $(0.05) Up From $(0.18) YoY Benzinga

08:45AM EST Titan Pharmaceuticals Reports Third Quarter 2020 Financial Results PR Newswire

Nov 9, 2020

10:09AM EST Stocks Trading Near 52-Week Lows Just After Open On Monday, Nov. 9, 2020: ABCM, SOAC, KOR, BVXV, HPR, BIIB, CTRM, TTNP, ASMB Benzinga

Nov 6, 2020

02:45PM EST Stocks Trading Near 52-Week Lows On Friday, Nov. 6, 2020: ASRT, KBLMU, PNRG, YGMZ, APRE, UHT, LAIX, CLI, CORR, ANIP, CCOI, KBLM, NYC, UTL, PEI, TIG, EYEG, PVL, ZSAN, TTNP, NBRV, SFT, WPG, IFS, COGT, LMNL, PRFX, GBT, FNHC, ASMB, EPZM, UCL Benzinga

07:47AM EST The Daily Biotech Pulse: Novartis Drug Flunks COVID-19 Study, Molecular Templates' Blood Cancer Study Placed On Partial Hold Benzinga

Nov 5, 2020

07:54AM EST The Daily Biotech Pulse: Bluebird Bio Plunges On Regulatory Filing Delay, Synlogic Soars On Study Initiation, European Label Expansion For Vertex, Merck Goes Shopping Benzinga

Nov 4, 2020

10:07AM EST Stocks Trading Near 52-Week Lows Just After Open On Wednesday, Nov. 4, 2020: NVCN, BBI, MFGP, TIG, DNK, GLOG, TRHC, HAPP, WG, TTNP, ATIF, CHEK, ARRY, GLSI, ETACW Benzinga

08:21AM EST The Daily Biotech Pulse: Alzheimer's Conference Underway, Biogen's Aducanumab Briefing Doc, Supernus Earnings Benzinga

Nov 3, 2020

09:15AM EST Stocks Trading Near 52-Week Lows Before Open On Tuesday, Nov. 3, 2020: UAN, TTNP, AIV Benzinga

07:38AM EST The Daily Biotech Pulse: Aurinia Pulls The Plug On Dry Eye Disease Study, Karyopharm's Positive Readout, Emergency Use Authorization For OraSure Benzinga

Nov 2, 2020

09:10AM EST Stocks Trading Near 52-Week Lows Before Open On Monday, Nov. 2, 2020: CLSN, MRTN, UTSI, LXRX, TTNP, ORTX, ARTL, PEI, CBL Benzinga

08:07AM EST Titan Pharma Completes Debt Settlement With Molteni And Horizon & Acquisiton Of JT's Kappa Opioid Agonist Peptide, JT-09 RTTNews

08:02AM EST Titan Pharmaceuticals Completes Debt Settlement With Molteni And Horizon & PR Newswire

Oct 28, 2020

04:12PM EDT Why Titan Pharmaceuticals Stock Is Trading Higher Today Benzinga

03:01PM EDT Titan Pharmaceuticals Announces Pricing Of $8.0 Million Underwritten Public Offering Of 80M Units At $0.10/Unit Benzinga

03:00PM EDT Titan Pharmaceuticals Announces Pricing of $8.0 Million Underwritten Public PR Newswire

08:12AM EDT Titan Pharma Signs Definitive Deal To Buy JT Pharma's Kappa Opioid Agonist Peptide, JT-09 RTTNews

08:03AM EDT Titan Pharma Reports Deal To Buy JT Pharma's Kappa Opioid Agonist Peptide, JT-09; Closing Of Deal Subject To Closing Conditions, Titan's Completion Of Financing With Gross Proceeds OF At Least $8M Benzinga

08:03AM EDT Titan Pharmaceuticals Enters Into Definitive Agreement To Acquire JT Pharma's PR Newswire

Oct 26, 2020

06:38AM EDT Titan Pharma Announces Debt Settlement Agreement With Molteni And Horizon RTTNews

06:37AM EDT Titan Pharmaceuticals Announces an Agreement to Settle its Debt Obligations with Molteni and Horizon Credit Benzinga

06:30AM EDT Titan Pharmaceuticals Announces Debt Settlement Agreement with Molteni and PR Newswire

Oct 21, 2020

08:04AM EDT The Daily Biotech Pulse: Prothena Progress In Parkinson's Disease Pipeline, Fast Track For Xeris, Biogen Earnings Benzinga

Oct 20, 2020

08:17AM EDT The Daily Biotech Pulse: Aptinyx Jumps On Positive Readout, Cara Executes Korsuva Licensing Deal, Cleveland BioLabs Rallies On Reverse Merger Benzinga

Oct 19, 2020

05:15PM EDT Titan Pharma S-1 Shows Registration For ~$11.4M Share Common Stock Offering Benzinga

Oct 15, 2020

08:14AM EDT Titan Pharmaceuticals Provides Strategic & Corporate Update Benzinga

Sep 24, 2020

09:03AM EDT Titan Pharmaceuticals Reports Pricing Of $2.7 Mln Direct Offering RTTNews

09:02AM EDT Titan Pharmaceuticals Announces Pricing of $2.7 Million Registered Direct PR Newswire

09:02AM EDT Titan Pharmaceuticals Announces Pricing Of $2.7M Direct Offering At $0.14/Share Benzinga

Sep 18, 2020

04:49PM EDT Titan Pharmaceuticals Stockholders Approve The Proposal To Amend Its Certificant Of Incorporation And Increase The Number Of Authorized Shares Of Its Common Stock From 125M To 225M Shares Benzinga

04:45PM EDT Titan Pharmaceuticals' Stockholders Approve Proposal To Amend Its Certificate PR Newswire

Sep 15, 2020

08:33AM EDT Titan's Probuphine Commercialization Partner, Molteni, Enters Into Exclusive European Distribution Agreement With Accord Healthcare Benzinga

08:31AM EDT Titan's Probuphine(r) Commercialization Partner, Molteni, Enters Into Exclusive PR Newswire

Sep 14, 2020

08:33AM EDT Titan Pharmaceuticals Provides Update To Stockholders On Proposal To Amend Its Certificate Of Incorporation Benzinga

08:31AM EDT Titan Pharmaceuticals Provides Update To Stockholders On Proposal To Amend Its PR Newswire

Aug 20, 2020

06:04AM EDT Titan Pharmaceuticals Says Nasdaq Provided Company With Time To Submit A Plan To Regain Compliance With Minimum Stockholders Equity Standard Benzinga

Aug 17, 2020

12:38PM EDT Maxim Group Downgrades Titan Pharmaceuticals to Hold Benzinga

Aug 14, 2020

08:51AM EDT Titan Pharma Q2 Net Loss $4.6 Mln Or $0.05/shr Vs. Loss $5.2 Mln Or $0.38/shr Prior Year RTTNews

08:46AM EDT Titan Pharmaceuticals Q2 EPS $(0.05) Up From $(0.38) YoY Benzinga

08:45AM EDT Titan Pharmaceuticals Reports Second Quarter 2020 Financial Results PR Newswire

Aug 10, 2020

04:31PM EDT Titan Pharmaceuticals To Report Second Quarter 2020 Financial Results On August PR Newswire

Share